文献速递糖尿病

在30月龄前起病的1型糖尿病患者中寻找单基因自身免疫性糖尿病病因

Searching for Monogenic Autoimmune Etiology in Patients With Type 1 Diabetes Onset Before 30 Months of Age.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

研究在500例西班牙儿童1型糖尿病患者中筛选9至30月龄起病者44例,采用定制panel的下一代测序检测单基因自身免疫性糖尿病相关基因。在2例1岁前起病患者中检出STAT5B c.286-12_290del和FOXP3 c.-22-2delA两个可能致病的新发剪接位点变异,RNA分析证实二者均改变mRNA剪接。结论认为1岁内起病的1型糖尿病可能提示单基因自身免疫性糖尿病,可推荐进行分子检测。

要点

  • 44例9至30月龄起病的西班牙儿童1型糖尿病患者接受单基因自身免疫性糖尿病基因筛查。
  • 2例1岁前起病者检出STAT5B与FOXP3可能致病的新发剪接位点变异。
  • RNA分析显示两变异分别导致外显子4跳跃和转录起始位点前16个核苷酸缺失。

核心结论

  • 1岁内起病的1型糖尿病可能提示单基因自身免疫性糖尿病,可推荐进行分子检测。

研究设计与样本

  • 在500例西班牙儿童1型糖尿病患者中选取9至30月龄起病者44例进行单基因自身免疫性糖尿病筛查。
  • 采用包含AIRE、CTLA4、FOXP3、IL2RA、ITCH、LRBA、STAT1、STAT3、STAT5B等主要致病基因的定制panel进行下一代测序。
  • 采用全血RNA的RT-PCR及cDNA测序分析剪接变异。

主要发现

  • 在2例1岁前起病的患者中检出2个影响经典剪接位点的可能致病新发变异:STAT5B c.286-12_290del和FOXP3 c.-22-2delA。
  • RNA分析证实两变异均改变mRNA剪接:STAT5B变异诱导外显子4跳跃,FOXP3变异导致转录起始位点前16个核苷酸缺失。

临床怎么用

  • 作者认为1岁内起病的1型糖尿病可能提示单基因自身免疫性糖尿病,可推荐进行分子检测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The most frequent form of diabetes in pediatric patients is polygenic autoimmune diabetes (type 1 diabetes [T1D]), but single-gene variants responsible for autoimmune diabetes have also been described. Both disorders share clinical features, which can lead to monogenic forms being misdiagnosed as T1D. However, correct diagnosis is crucial for therapeutic choice, prognosis, and genetic counseling. The aim of this study was to search for monogenic autoimmune diabetes in Spanish pediatric patients with early-onset T1D. METHODS: Among 500 Spanish pediatric patients with T1D, those with disease onset between 9 and 30 months of age were selected for screening for monogenic autoimmune diabetes (n = 44). Genetic testing was performed by next-generation sequencing with a customized panel that included the major causative genes for monogenic autoimmune syndromes, including early-onset diabetes: AIRE, CTLA4, FOXP3, IL2RA, ITCH, LRBA, STAT1, STAT3, STAT5B. RT-PCR and cDNA sequencing of the RNA isolated from whole blood were used to analyze splicing variants. RESULTS: Genetic screening identified, in 2 patients with diabetes onset before 1 year of age, 2 likely pathogenic novel variants affecting canonical splicing sites: c.286-12_290del in STAT5B and c.-22-2delA in FOXP3. RNA analyses demonstrated that both variants modify mRNA splicing. The variant in STAT5B induced exon 4 skipping and the variant in FOXP3 caused a deletion of 16 nucleotides before the transcription start site. CONCLUSION: T1D onset in the first year of life may indicate monogenic autoimmune diabetes and molecular testing may be recommended.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Saso-Jiménez L, Urrutia I, Calvo B, et al. Searching for Monogenic Autoimmune Etiology in Patients With Type 1 Diabetes Onset Before 30 Months of Age. J Clin Endocrinol Metab. 2025. PMID: 39870583. doi:10.1210/clinem/dgaf049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。